Xellia Pharms Aps Drug Patent Portfolio

Xellia Pharms Aps's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Xellia Pharms Aps News

Hikma Pharmaceuticals to acquire portions of a Danish competitor in a transaction valued at up to £146 million, as reported by This is Money.

17 Jun, 2024

See More